62 results
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
by the aggregate cost of Products purchased for such period) (“Material Suppliers”). No Material Supplier has notified TXMD or any member of the TXMD Group … , individually or in the aggregate, to be material to the Product Exploitation. To TXMD’s Knowledge, (a) each supplier of TXMD and the TXMD Group or any
8-K
EX-2.1
TXMD
TherapeuticsMD Inc
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
, certificates of need, supplier or provider numbers, exemptions, registrations, listing, concessions or other authorizations required to have been
8-K
EX-2.1
b89vlzz z1
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
S-3ASR
EX-1.2
tcxi7ac2t il
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-1.1
hy34ma qtp0hi0fgqi
16 Feb 21
Entry into a Material Definitive Agreement
8:35am
8-K
EX-1.1
3fyjc
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-1.1
6d3843xh10th34u98
13 Nov 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
7s7a4pluxviofbnps3
29 Oct 19
Entry into a Material Definitive Agreement
8:52am
8-K
EX-99.1
9kxwgpes9vp5di5d8mz2
13 Aug 18
TherapeuticsMDAnnounces FDA Approval of ANNOVERA ™(Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control
6:01am